Exozymes EXOZ Cash Flow Statement (2023-2026)

NASDAQ EXOZ
$7.04 +0.64 (+10.00%)
At close: Aug 20, 2026 · 4:00 PM EDT
Cash Flow Statement Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Jun2026
Operating Activities
Net Income (Quarter) -0.52M-1.06M-1.01M-1.36M-1.66M-0.61M-1.86M-2.36M-2.29M-2.76M-2.88M
Depreciation and Depletion (Quarter) 0.05M0.06M0.06M0.07M0.07M0.07M0.07M0.07M0.07M0.07M
Share-based Compensation (Quarter) 0.06M0.11M0.14M0.35M4.87M0.32M0.32M0.24M3.07M0.68M0.96M
Cash from Operations (Quarter) -0.78M0.28M-2.54M-0.54M-5.71M-1.13M-1.54M-1.86M-1.97M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter) -0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M
Depreciation & Amortization (CF) (Quarter) 0.05M0.06M0.06M0.07M0.07M0.07M0.07M0.07M0.07M0.07M
Change in Working Capital
Change in Receivables (Quarter) 0.21M0.23M0.04M-0.59M0.18M-0.14M-0.34M0.05M0.21M
Change in Account Payables (Quarter) 0.01M1.32M-1.22M-0.10M-4.25M0.01M-0.01M
Change in Accured Expenses (Quarter) 0.40M0.05M-0.41M0.27M0.30M0.15M-0.14M-0.03M0.33M
Change in Taxes (Quarter) -0.00M-0.04M
Other Working Capital Changes (Quarter) 0.11M0.06M-0.11M0.03M0.12M-0.05M-0.02M-0.09M0.18M
Investing Activities
Capital Expenditures (Quarter) 0.11M0.15M0.04M0.21M0.03M0.05M0.01M0.07M
Cash from Investing Activities (Quarter) -0.11M-0.14M-0.04M0.03M-0.21M-0.03M-0.03M-0.01M-0.07M
Financing Activities
Cash from Financing Activities (Quarter) 0.48M-0.09M2.62M0.59M15.40M-0.04M-0.01M
Additional items
Change in Cash (Quarter) -0.41M0.05M0.04M0.08M9.49M-1.21M-1.53M-1.89M-2.06M
Free Cash Flow (Quarter) -0.89M0.13M-2.58M-0.54M-5.92M-1.16M-1.59M-1.87M-2.05M
Net Cash Flow (Quarter) -0.41M0.05M0.04M0.08M9.49M-1.21M-1.57M-1.87M-2.06M